Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — Q1 2025 Earnings Presentation
35 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, May 15, 2025
Slide 1: Q1 2025 Investor Presentation
Q1 2025 Investor Presentation As of 15 May 2025
Slide 2: Presenting Team
Presenting Team Ziyad Al Dahami Faisal Al Nassar Esam Al Mashloum Head of Investor Relations and Treasury Chief Executive Officer Vice President, Finance Q1 2025 HMG Investor Presentation
Slide 3: Agenda
Agenda 1 Financial Performance 2 Projects Update 3 Q&A Key Financial Highlights 5 Projects Update 10 Q&A 11 Balance Sheet Highlight 6 Leverage Levels 7 Total Cash Dividends For 8 Shareholders Appendices Appendix #1 Appendix #2 Appendix #3 4 Operational Highlights 5 Summarized Financials 6 About HMG
Slide 4: Financial Performance
1 Financial Performance
Slide 5: Key Financial Highlights: Q1 2025
Key Financial Highlights: Q1 2025 Gross profit 17.21% Gross profit Margin Q1 2025 1,028.31 Q1 2025 32.56% Q1 2024 877.33 Q1 2024 34.80% EBITDA 19.81% EBITDA margin 816.05 Q1 2025 Q1 2025 25.84% 681.12 Q1 2024 Q1 2024 27.01% Net income 1.10% Net income margin Q1 2025 557.01 17.64% Q1 2025 Q1 2024 550
Slide 6: Balance Sheet Highlights
Balance Sheet Highlights million ROE ROA Q1 2024 Q1 2025 Total assets Total assets 32.0% 11.7% 16,849 21,361 Cash and Current Cash and Current bank liabilities bank liabilities 34.7% 14.4% 2,529 3,434 2,548 4,431 15.01% 11.93% 20.74% 20.38% Accounts Accounts ROCE Current Ratio receivable receivable
Slide 7: Leverage Levels
Leverage Levels 120.00% Total liabilities and equity million Liabilities/Total Assets Liabilities/Equity Q1 2025 0.64x Q1 2025 1.76x 100.00% Q1 2024 0.59x Q1 2024 1.43x 80.00% 41.17% 36.29% 6,936.32 7,751.75 Debt / Equity Net Debt / EBITDA 60.00% Q1 2025 1.11x Q1 2025 1.87x 0.85x Q1 2024 1.24x Q1 20
Slide 8: Declared Cash Dividends
Declared Cash Dividends Declared Cash Dividends – Q1 2025 Declared Dividends Pay-out Current Capital 3.5 billion 2025 1.12 per share 392.0 mn 70.4% Number of Shares 350 million 1.23 per share 430.5 mn 70.1% Dividend to be Distributed 392 million 1.20 per share 420.0 mn 70.5% 2024 % of Capital 11.2%
Slide 9: Projects Update
2 Projects Update
Slide 10: Projects Update
Projects Update Solidifying our market leadership through robust expansion plans and progressing our projects Sehat Al Hamra Hospital 90+ Khobar Medical Center Sehat Al Kharj Hospital 140+ Ownership Opened on Riyadh Ownership Opened on Khobar Ownership Opening on Kharj 100% Jan.2025 Feb. 2025 100% 2
Slide 11: Operational Highlights
4 Appendix #1 Operational Highlights
Slide 12: Q1 2025 Highlights
Q1 2025 Highlights Opening of Hamra Cooperation agreement with University National Patient Safety Award in Hospital in Riyadh Established Dr. Sulaiman Al of Jeddah to support training, the Maternal and Newborn Safety Habib College of Knowledge, a employment, and the development of Category nursing c
Slide 13: Medical Excellence
Medical Excellence Creating the medical practitioners of the future and promoting health and well-being Continuous Medical Research Center Postgraduate Program Education 1 Journal issued 60+ Activities 100+ Hours 42 30 research paper published Residency & Fellowship program in 35+ Research proposals
Slide 14: ESG Highlight
ESG Highlight ▪ Developed and formalized core ESG policies to guide responsible operations: o A Human Rights Policy promoting equity, safety, and dignity across our value chain. o A Sustainability Policy embedding ESG into day-to-day decision-making. o An Anti-Corruption and Anti-Bribery Policy stre
Slide 15: Our People
Our People We continue to attract and retain top talent 60% female Physician Qualifications 26,000+ Employees 40% male Staff ratio 44% 5,000+ 90%+ Physicians Retention Rate 23% 85+ 33% Nationalities Saudization 33% Training via Virtual Academy Platform Saudi Western (Including North America and UK)
Slide 16: HMG App
HMG App Interaction Booked Appointments 205m + 1.37m interactions appointments Habib Live Care Home Healthcare + 82.8k + 8.7k transactions transactions Q1 2025 HMG Investor Presentation 16
Slide 17: Investment Case
Investment Case Attractive Industry Fundamentals HMG is committed to patient safety and wellbeing, providing patients with the highest standards of Adaptable Operating Model medical technology, exceptional patient experiences and sustainability to consistently deliver best-in-class care through its
Slide 18: Summarized Financials
5 Appendix #2 Summarized Financials
Slide 19: Financial Review
Financial Review Key Financial Information and KPIs Q1-2025 Q1-2024 Statement of Income million Revenue 3,158 2,521 Gross profit 1,028 877 Operating income 626 556 Profit attributable to equity holders of the parent 557 551 Balance Sheet million Current assets 5,244 4,171 Non-current assets 16,117 1
Slide 20: Financial Review (Continued)
Financial Review (Continued) Key Financial Information and KPIs Q1-2025 Q1-2024 Cash Flows million Net cash from operating activities 734 796 Net cash used in investing activities (934) (1,062) Net cash used in financing activities (143) 175 Cash and Cash Equivalents, Beginning of the Period 2,891 2
Slide 21: About HMG
6 Appendix #3 About HMG
Slide 22: About HMG
About HMG HMG continues to elevate healthcare delivery and innovation across the Kingdom and the region. Our reputation for providing personalized subsidiaries positions us at the forefront of patient experience supported by cutting- the industry as we continually seek to edge technology across our
Slide 23: About HMG (Continued)
About HMG (Continued) Our Values shape our identity, giving us an unwavering sense Our of purpose and motivation to deliver the best results to all Values our stakeholders. These Values guide our strategic decisions and anchor us to our Vision and Mission. Integrity and trust Care for patients Safet
Slide 24: Key Message
Key Message Strategic pillars underpin our drive to deliver best-in-class healthcare services Catalysts for value Best-in-class Efficiency drivers creation • Technology: Pioneer in healthcare • Efficient cash conversion cycle: • Regional integrated healthcare technology, award-winning hospital short
Slide 25: Geographic Footprint
Geographic Footprint Sahafa (Riyadh) Hamra (Riyadh) Tabuk Olaya (Riyadh) Fayhaa (Jeddah) NEOM Rayan (Riyadh) Qassim Takhassusi (Riyadh) Khobar Suwaidi (Riyadh) Dubai Jubail Women’s Health (Riyadh) Qassim Industrial City Khobar Sehat Al Kharj (Kharj)* Tabuk Muhammadiyah (Jeddah)** Jubail (Jubail Indu
Slide 26: Geographic Footprint (Continued)
Geographic Footprint (Continued) Our Riyadh Presence MAP KEY Hospitals Medical Centers Head Office HMG Academy Urgent Care Q1 2025 HMG Investor Presentation 26
Slide 27: Strategy
Strategy OUR PILLARS Drivers Outcomes Our Growth Strategy Strengthening • Rigorous quality and safety standards • Patient and customer-centric Our forward-thinking corporate strategy creates sustainable value • Top-notch empowered employees value service delivery the Core for our shareholders and st
Slide 28: Business Model
Business Model OUR KEY STRENGTHS WHAT WE DO HMG is uniquely positioned as the leading • Forefront Of Technology and Innovation • Modern Facilities and Comprehensive Services private healthcare group in the region, with the expertise, experience and culture • Trusted Brand in Prime Locations • Sustai
Slide 29: Medical Operation Strategic Pillars
Medical Operation Strategic Pillars Our Fundamental Strategic Pillars Patient Experience Standardization of Care Performance and Since its foundation, transformation and evolution, HMG has Efficiency always abided by five key strategic pillars that form the basis of our Enhancing patient experience
Slide 30: Pioneer In Healthcare Technology
Pioneer In Healthcare Technology Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine Developing cutting edge technology HIS (VIDA) 80 Vida implemented sites Pioneer in healthcare technology, award-winning ▪ Tele-Cardiology (Nabad 24 program): Des
Slide 31: Board of Directors
Board of Directors Non-executives Executives Independents Dr. Sulaiman Al Habib Mr. Faisal Al Nassar Mr. Obaid Al Rasheed Board member, Group CEO and Group Founder and Chairman Vice Chairman CFO Dr. Abdulrahman Al Turaigi Mr. Hesham Al Habib Eng. Saleh Al Habib Board member Board member and Chief Bo
Slide 32: Committee Members
Committee Members Audit Nomination and Remuneration Executive Dr. Abdulrahman Al Turaigi Mr. Obaid Al Rasheed Eng. Saleh Al Habib Chairman Chairman Chairman Mr. Turki Al Luhaid Eng. Saleh Al Habib Mr. Faisal Al Nassar Member Member Member Mr. Abdulaziz Al Haidari Mr. Rasheed Al Rasheed Mr. Hesham Al
Slide 33: Executive Management
Executive Management Highly experienced, high caliber management Mr. Faisal Al Nassar CEO & President CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Prof. Abdullah Al Herbish Mr. Hesham Al Habib Chief Business Mr. Ahmed Babatin Eng. Abdullah Dr. Riyad Al Atiqi Senior Vice President, Develo
Slide 34: Disclaimer
Disclaimer Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm
Slide 35: Thank You
Investor Relations Department Thank You King Fahad Road, Olaya District P.O. Box: 91877, Riyadh 11643, Kingdom of Saudi Arabia Phone: + 966 (11) 5259999, Ex. 4919 Fax: + 966 (11) 2174980 Email: investor.relations@drsulaimanalhabib.com OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE
Dr. Sulaiman Al Habib Medical Services Group (HMG) — Q1 2025 Earnings Presentation on 6ix